Not applicableUnknownNCT06134635What this trial is testingShort-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke Xuanwu Hospital, Beijing 80
Post-approval studies (Phase 4)Study completedNCT03096288What this trial is testingImpact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet ReactivityWho this might be right forAtherosclerotic Cardiovascular Disease University of Florida 259
Testing effectiveness (Phase 2)Study completedNCT04173793What this trial is testingPCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)Who this might be right forHeterozygous Familial Hypercholesterolemia Akeso 109
Testing effectiveness (Phase 2)Study completedNCT03815812What this trial is testingMultiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With HypercholesterolemiaWho this might be right forHypercholesterolemia Innovent Biologics (Suzhou) Co. Ltd. 60
Post-approval studies (Phase 4)UnknownNCT05298475What this trial is testingLow-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary SyndromeWho this might be right forAcute Coronary Syndrome The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)UnknownNCT06304987What this trial is testingNeoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal CancerWho this might be right forLocally Advanced Rectal Cancer Beijing Friendship Hospital 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07290699What this trial is testingIntensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative PeriodWho this might be right forSTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) Second Affiliated Hospital of Nanchang University 2,442
Post-approval studies (Phase 4)Study completedNCT04608474What this trial is testingLipid Management in Renal Transplant Recipients Using Evolocumab.Who this might be right forHyperlipidemias Brigham and Women's Hospital 81
Early research (Phase 1)Study completedNCT04197817What this trial is testingA Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health SubjectsWho this might be right forHypercholesterolemia Shanghai Junshi Bioscience Co., Ltd. 84
Post-approval studies (Phase 4)Not Yet RecruitingNCT06083961What this trial is testingThe Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid ProfileWho this might be right forStroke, Acute IschemicPCSK9 Inhibitor Sun U. Kwon 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07605130What this trial is testingEfficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter TrialWho this might be right forIntracranial ArteriosclerosisCognitive Impairment Peking Union Medical College Hospital 440
Post-approval studies (Phase 4)UnknownNCT05976893What this trial is testingStudy on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and CancerWho this might be right forASCVDAtherosclerotic Cardiovascular DiseaseProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor+1 more Xiang Xie 620
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07062328What this trial is testingA Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTCWho this might be right forBiliary Tract Carcinoma Sun Yat-sen University 39
Large-scale testing (Phase 3)Study completedNCT06696820What this trial is testingEfficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke Xiang Luo 429
Post-approval studies (Phase 4)Not Yet RecruitingNCT06683131What this trial is testingEffectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction PatientsWho this might be right forAcute Myocardial Infarction (AMI) The Affiliated Hospital of Xuzhou Medical University 1,160
Testing effectiveness (Phase 2)Study completedNCT01375764What this trial is testingGoal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant SubjectsWho this might be right forHyperlipidemia Amgen 160
Testing effectiveness (Phase 2)Study completedNCT05261126What this trial is testingThe Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)Who this might be right forHypercholesterolemiaFamilial Hypercholesterolemia Merck Sharp & Dohme LLC 381
Not applicableUnknownNCT06034691What this trial is testingExploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCBWho this might be right forHemodialysis Access Failure RenJi Hospital 40
Not applicableNot Yet RecruitingNCT07674524What this trial is testingManagement Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLCWho this might be right forNon-Small Cell Lung Cancer (NSCLC)HyperlipidemiaALK Gene Mutation+1 more Sun Yat-sen University 160
Post-approval studies (Phase 4)Looking for participantsNCT05292404What this trial is testingImpact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium InfarctionWho this might be right forAcute Myocardial Infarction Shanghai Tong Ren Hospital 160